Statements (25)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:Company
|
| gptkbp:annualVisitors |
15%
|
| gptkbp:awards |
Best_Biotech_Company_2021
|
| gptkbp:CEO |
gptkb:John_Doe
|
| gptkbp:clinicalTrials |
Ongoing
|
| gptkbp:foundedIn |
2000
|
| gptkbp:founder |
gptkb:Alice_Johnson
|
| gptkbp:headCoach |
gptkb:Dr._Jane_Smith
|
| gptkbp:headquarters |
gptkb:California
gptkb:San_Francisco gptkb:United_States |
| https://www.w3.org/2000/01/rdf-schema#label |
Viva BioScience
|
| gptkbp:industry |
Biotechnology
|
| gptkbp:investmentFocus |
Venture_Capital_Firms
|
| gptkbp:market |
Global
|
| gptkbp:numberOfEmployees |
50
|
| gptkbp:partnerships |
Various pharmaceutical companies
|
| gptkbp:patentCitation |
20 patents granted
|
| gptkbp:products |
Therapeutics
|
| gptkbp:researchFocus |
Cell therapy
|
| gptkbp:revenue |
10 million USD
|
| gptkbp:services |
Research_and_Development
|
| gptkbp:specializesIn |
Biopharmaceuticals
|
| gptkbp:subsidiary |
gptkb:Viva_Therapeutics
|
| gptkbp:website |
www.vivabioscience.com
|